| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| ACURX Pharmaceutical | 2021-12 | Donations | 2024-12 |
ACURX Pharmaceutical |
4,870 | 4,870 | 0 | 0 | ||
| ALERGON Pharmaceutical | 2021-04 | Donations | 2024-04 |
ALERGON Pharmaceutical |
56 | 56 | 0 | 0 | ||
| BP PLC SPONSORED ADR | 2021-10 | Purchase | 2024-12 |
BP PLC SPONSORED ADR |
2,912 | 2,951 | 0 | 0 | ||
| COHBAR INC | 2021-04 | Donations | 2024-04 |
COHBAR INC |
419 | 419 | 0 | 0 | ||
| NYMOX PHARMACEUTICAL | 2021-05 | Donations | 2024-04 |
NYMOX PHARMACEUTICAL |
1,452 | 1,452 | 0 | 0 | ||
| STARBUCKS CORP | 2011-01 | Donations | 2024-09 |
STARBUCKS CORP |
3,862 | 3,862 | 0 | 0 | ||
| WARNER BROS DISCOUVERY | 2021-12 | Purchase | 2024-04 |
WARNER BROS DISCOUVERY |
404 | 1,103 | 0 | 0 | ||
| BLACKSTONE MORTGAGE TRUST | 2020-12 | Purchase | 2024-09 |
BLACKSTONE MORTGAGE TRUST |
5,983 | 7,839 | 4 | 0 |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Corporate Bonds | 0 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Equities @ Fidelity Investments | 331,244 | 331,244 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| NONE | 0 | 0 | 0 | 0 |
| Description | Amount |
|---|---|
| taxes expenses | 697 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| foreign Tax Paid | 53 | 0 | 0 | 0 |
| Transaction cost | 4 | 0 | 0 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| NON DIVIDEND DISTRIBUTION | 489 | 489 | 489 |
| Description | Amount |
|---|---|
| change in investment value | 47,527 |